Coinbase
COIN
Strategy
MSTR
Tesla
TSLA
4
Salesforce
CRM
5
Meta Platforms
META
US Stock MarketDetailed Quotes
RCKT Rocket Pharmaceuticals
- 8.090
- -0.500-5.82%
Trading Mar 11 12:32 ET
862.63MMarket Cap-2.96P/E (TTM)
8.660High8.060Low552.67KVolume8.540Open8.590Pre Close4.58MTurnover0.64%Turnover RatioLossP/E (Static)106.63MShares28.67052wk High1.86P/B697.71MFloat Cap8.06052wk Low--Dividend TTM86.24MShs Float67.480Historical High--Div YieldTTM6.99%Amplitude7.565Historical Low8.295Avg Price1Lot Size
About Rocket Pharmaceuticals Company
Rocket Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the development of gene therapy treatment options for rare and devastating pediatric diseases. Its multi-platform development approach applies the lentiviral vector and adeno-associated viral vector gene therapy platforms. Its clinical program is an LVV-based gene therapy for the treatment of Fanconi Anemia (FA), a difficult to treat genetic disease that leads to bone marrow failure and potentially cancer. The company was founded on July 7, 1999 and is headquartered in Cranbury, NJ.
Company Profile
SymbolRCKT
Company NameRocket Pharmaceuticals
Listing DateFeb 18, 2015
Issue Price6.00
Founded1999
CEODr. Gaurav Shah, M.D.
MarketNASDAQ
Employees299
Fiscal Year Ends12-31
Address9 Cedarbrook Drive
CityCranbury
ProvinceNew Jersey
CountryUnited States of America
Zip Code08512
Phone1-609-659-8001
Websitehttp://www.rocketpharma.com
Company Executives
- Name
- Position
- Salary
- Dr. Gaurav Shah, M.D.
- Director and Chief Executive Officer
- 8.01M
- Martin Wilson, J.D.
- Chief Corporate Officer, Senior Vice President, General Counsel and Chief Compliance Officer
- --
- Aaron Ondrey
- Chief Financial Officer
- --
- Jonathan Schwartz, M.D.
- Chief Medical Officer and Chief Gene Therapy Officer
- 3.16M
- Mayo Pujols
- Chief Technical Officer and Executive Vice President
- 4.38M
- Raj Prabhakar
- Chief Business Officer and Senior Vice President
- --
- Dr. Kinnari Patel, M.B.A.,Pharm.D.
- President, Chief Operating Officer and Head of R&D
- 4.85M
- John Militello, C.P.A.
- Vice President, Finance, Senior Controller, Treasurer and Principal Accounting Officer
- 1.53M
- Dr. Roderick Wong, M.D.
- Chairman of the Board
- 409.99K
- Dr. Mikael Dolsten, M.D.
- Director
- --
- Piratip Pratuwan
- Director
- --
- Robert Keith Woods
- Independent Director
- 568.70K
- Carsten Boess
- Independent Director
- 427.49K
- Dr. Gotham Makker, M.D.
- Independent Director
- 399.99K
- Dr. Fady Ibraham Malik, M.D.,PhD
- Independent Director
- 399.99K
- Dr. Elisabeth Bjork, M.D.,PhD
- Independent Director
- 409.99K
- Pedro P. Granadillo
- Independent Director
- 429.98K
- David P. Southwell
- Independent Director
- 399.99K
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Big Tech’s earnings season in full swing! Nvidia is the only one left
On Thursday, $Amazon (AMZN.US)$ stock fell after the firm reported Q4 adjusted earnings of $1.86/share, vs estimates of $1.50/share, on reve
Moo Earnings
Feb 2 12:39
AMZN earnings preview: Grab rewards by guessing the opening price!